Novel therapies for pancreatic adenocarcinoma (Q35739070)

10 August 2017

1 reference

title

Novel therapies for pancreatic adenocarcinoma (English)

1 reference

10 August 2017

1 reference

James Lewis Abbruzzese

series ordinal

4

object named as

James L Abbruzzese

1 reference

10 August 2017

Simona M Pino

1

1 reference

10 August 2017

Henry Q Xiong

series ordinal

2

1 reference

10 August 2017

David McConkey

series ordinal

3

1 reference

10 August 2017

publication date

1 May 2004

1 reference

10 August 2017

published in

Current Oncology Reports

1 reference

10 August 2017

volume

6

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

199-206

1 reference

Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0050-1

Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0050-1

New insights into the role of nuclear factor-kB in cell growth regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0050-1

Proof of mechanism of antisense drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0050-1

The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells

21 January 2018

1 reference

12 December 2020

Antisense oligonucleotides demonstrate a dominant role of c-Ki-RAS proteins in regulating the proliferation of diploid human fibroblasts

1 reference

12 December 2020

Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma

1 reference

12 December 2020

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study

1 reference

12 December 2020

K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization

1 reference

12 December 2020

Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma

1 reference

12 December 2020

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

12 December 2020

Cancer statistics, 2003.

1 reference

12 December 2020

Tumor angiogenesis: therapeutic implications

1 reference

12 December 2020

Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design

1 reference

12 December 2020

Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial

1 reference

12 December 2020

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer

1 reference

12 December 2020

A matrix metalloproteinase expressed on the surface of invasive tumour cells

1 reference

12 December 2020

Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma

1 reference

12 December 2020

Cyclooxygenase-2 expression in human pancreatic adenocarcinomas

1 reference

12 December 2020

Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors

1 reference

12 December 2020

Blockade of receptors for growth factors: an anticancer therapy--the fourth annual Joseph H Burchenal American Association of Cancer Research Clinical Research Award Lecture

1 reference

12 December 2020

Pancreatic tumors show high levels of hypoxia

1 reference

12 December 2020

Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer

1 reference

12 December 2020

Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo

1 reference

12 December 2020

Inhibition of the phosphatidylinositol 3'-kinase signaling pathway increases the responsiveness of pancreatic carcinoma cells to sulindac

1 reference

12 December 2020

Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells

1 reference

12 December 2020

Blocking oncogenic Ras signaling for cancer therapy

1 reference

12 December 2020

Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.

1 reference

12 December 2020

p21ras is modified by a farnesyl isoprenoid

1 reference

12 December 2020

Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma

1 reference

12 December 2020

Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu

1 reference

12 December 2020

Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms

1 reference

12 December 2020

Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides

1 reference

12 December 2020

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

Continuing controversy over adjuvant therapy of pancreatic cancer

1 reference

12 December 2020

10.1007/S11912-004-0050-1

Identifiers

DOI

1 reference

10 August 2017

1 reference